About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [307 citations: 201–291 of 291 articles]

Articles published in Prostate Cancer have been cited 307 times. The following is a list of the 291 articles that have cited the articles published in Prostate Cancer.

  • Renato A. Valdes-Olmos, Nynke S. van den Berg, and Henk G. van der Poel, “Sentinel Lymph Node Biopsy for Prostate Cancer: A Hybrid Approach,” Journal Of Nuclear Medicine, vol. 54, no. 4, pp. 493–496, 2013. View at Publisher · View at Google Scholar
  • Katsumi Shigemura, Nozomu Yamanaka, and Masuo Yamashita, “Can Diffusion-Weighted Magnetic Resonance Imaging Predict a High Gleason Score of Prostate Cancer?,” Korean Journal of Urology, vol. 54, no. 4, pp. 234, 2013. View at Publisher · View at Google Scholar
  • James J Cody, Angel A Rivera, Gray R Lyons, Sherry W Yang, Minghui Wang, Jason W Ashley, Sreelatha Meleth, Xu Feng, Gene P Siegal, and Joanne T Douglas, “Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model,” Laboratory Investigation, vol. 93, no. 3, pp. 268–278, 2013. View at Publisher · View at Google Scholar
  • Oscar R. Brouwer, A. Noe, Renato A. Valdés Olmos, and Axel Bex, “Lymphatic Drainage from Renal Cell Carcinoma along the Thoracic Duct Visualized with SPECT/CT,” Lymphatic Research and Biology, vol. 11, no. 4, pp. 233–238, 2013. View at Publisher · View at Google Scholar
  • Paul Posadzki, Myeong Soo Lee, Igho Onakpoya, Hye Won Lee, Byong Seob Ko, and Edzard Ernst, “Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials,” Maturitas, vol. 75, no. 2, pp. 125–130, 2013. View at Publisher · View at Google Scholar
  • Raúl Baena Ruiz, and Pedro Salinas Hernández, “Diet and Cancer: Risk factors and epidemiological evidence,” Maturitas, 2013. View at Publisher · View at Google Scholar
  • Xue Rui, Ma Shengli, Jia Zhankui, Pi Guofu, and Yang Jinjian, “HMGB1: A potential target for treatment of benign prostatic hyperplasia,” Medical Hypotheses, 2013. View at Publisher · View at Google Scholar
  • Tobias Pommer, Marianne Falk, Per Rugaard Poulsen, Paul J. Keall, Ricky T. O’Brien, and Per Munck af Rosenschöld, “The impact of leaf width and plan complexity on DMLC tracking of prostate intensity modulated arc therapy,” Medical Physics, vol. 40, no. 11, pp. 111717, 2013. View at Publisher · View at Google Scholar
  • S. Belikov, C. Öberg, T. Jääskeläinen, V. Rahkama, J.J. Palvimo, and Ö. Wrange, “FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide™),” Molecular and Cellular Endocrinology, vol. 365, no. 1, pp. 95–107, 2013. View at Publisher · View at Google Scholar
  • Sara Pignatta, Chiara Arienti, Wainer Zoli, Marzia Di Donato, Gabriella Castoria, Elisa Gabucci, Valentina Casadio, Mirella Falconi, Ugo De Giorgi, Rosella Silvestrini, and Anna Tesei, “Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome,” Molecular and Cellular Endocrinology, 2013. View at Publisher · View at Google Scholar
  • Trinath P. Das, Suman Suman, and Chendil Damodaran, “Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells,” Molecular Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  • Isaac J. Powell, and Aliccia Bollig-Fischer, “Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities,” Molecular Endocrinology, vol. 27, no. 6, pp. 879–891, 2013. View at Publisher · View at Google Scholar
  • Paloma Olvera-Caltzontzin, Guadalupe Delgado, and Carmen Aceves, “Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model,” Molecular Medicine, vol. 19, pp. 409–416, 2013. View at Publisher · View at Google Scholar
  • Kimberley Carter, “Advances in prostate cancer treatment,” Nature Reviews Drug Discovery, vol. 12, no. 11, pp. 823–824, 2013. View at Publisher · View at Google Scholar
  • Ashwin N. Sridhar, Archie Hughes-Hallett, Erik K. Mayer, Philip J. Pratt, Philip J. Edwards, Guang-Zhong Yang, Ara W. Darzi, and Justin A. Vale, “Image-guided robotic interventions for prostate cancer,” Nature Reviews Urology, 2013. View at Publisher · View at Google Scholar
  • Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, and Robert B. Den, “Evolution of advanced technologies in prostate cancer radiotherapy,” Nature Reviews Urology, 2013. View at Publisher · View at Google Scholar
  • K. Franke, M. Baur, L. Daum, M. Vaegler, K.-D. Sievert, and B. Schlosshauer, “Prostate carcinoma cell growth-inhibiting hydrogel supports axonal regeneration in vitro,” Neuroscience Letters, vol. 541, pp. 248–252, 2013. View at Publisher · View at Google Scholar
  • L. Y. Aydin, A. K. Uzunlar, K. Cam, A. Tekin, H. Erdem, U. Yildirim, C. Sahiner, M. A. Kayikci, M. Oktay, and H. Ankarali, “Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas,” Nigerian Journal Of Clinical Practice, vol. 16, no. 4, pp. 418–423, 2013. View at Publisher · View at Google Scholar
  • Georgia Lenihan-Geels, Karen S. Bishop, and Lynnette R. Ferguson, “Alternative Sources of Omega-3 Fats: Can We Find a Sustainable Substitute for Fish?,” Nutrients, vol. 5, no. 4, pp. 1301–1315, 2013. View at Publisher · View at Google Scholar
  • Hueseyin Sirma, Margarethe Broemel, Laura Stumm, Tina Tsourlakis, Stefan Steurer, Pierre Tennstedt, Georg Salomon, Uwe Michl, Alexander Haese, Ronald Simon, Guido Sauter, Thorsten Schlomm, and Sarah Minner, “Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis,” Oncology Letters, vol. 6, no. 5, pp. 1245–1252, 2013. View at Publisher · View at Google Scholar
  • Joanne M. Harrington, Dawn C. Schwenke, Dana R. Epstein, and Donald E. Bailey, “Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer,” Oncology Nursing Forum, vol. 41, no. 1, pp. 21–29, 2013. View at Publisher · View at Google Scholar
  • Hifzur Rahman Siddique, Aijaz Parray, Weixiong Zhong, R. Jeffery Karnes, Eric J. Bergstralh, Shahriar Koochekpour, Johng S. Rhim, Badrinath R. Konety, and Mohammad Saleem, “BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer,” Plos One, vol. 8, no. 1, 2013. View at Publisher · View at Google Scholar
  • Maja Narlik-Grassow, Carmen Blanco-Aparicio, Yolanda Cecilia, Marco Perez, Sandra Munoz-Galvan, Marta Canamero, and Amancio Carnero, “Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Hasan Mukhtar, Aijaz Parray, R. Jeffery Karnes, Yibin Deng, Badrinath R. Konety, Mohammad Saleem, Hifzur Rahman Siddique, Rohinton S. Tarapore, and Lei Wang, “BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling,” Plos One, vol. 8, no. 5, 2013. View at Publisher · View at Google Scholar
  • Elisabeth Gustafson-Wagner, and Christopher S. Stipp, “The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate alpha 3 beta 1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Changsheng Xing, Xiaodong Sun, Peng Guo, Mei Li, Xiaoying Fu, and Jin-Tang Dong, “Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells,” Plos One, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Peter H. Gann, Mahesh Mohnani, Erika Enk Rueter, Anup Amatya, Ryan Deaton, Yirong Yang, and Viju Ananthanarayanan, “Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Susan E. Erdman, Bruce H. Horwitz, Tatiana Levkovich, Chung-Wei Lee, Zhongming Ge, Theofilos Poutahidis, Kelsey Cappelle, Michael Doulberis, and James G. Fox, “Pathogenic Intestinal Bacteria Enhance Prostate Cancer Development via Systemic Activation of Immune Cells in Mice,” Plos One, vol. 8, no. 8, 2013. View at Publisher · View at Google Scholar
  • N.G. Agoua, E. Vian, M. Dumoulin, and P. Blanchet, “Résultats de la radiothérapie de rattrapage pour récidive biologique après prostatectomie radicale dans la population africaine-caribéene de la Guadeloupe,” Progrès en Urologie, vol. 23, no. 2, pp. 128–136, 2013. View at Publisher · View at Google Scholar
  • H. Haddad, N. Sellal, and Z. Bourhaleb, “Carcinome à cellules en bague à chaton primitif de la prostate : une entité rare,” Progrès en Urologie, 2013. View at Publisher · View at Google Scholar
  • L Hughes, K Ruth, T R Rebbeck, and V N Giri, “Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men,” Prostate Cancer and Prostatic Disease, 2013. View at Publisher · View at Google Scholar
  • Georgios Gakis, Arnulf Stenzl, and Markus Renninger, “Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?,” Scandinavian Journal of Urology, vol. 47, no. 5, pp. 358–362, 2013. View at Publisher · View at Google Scholar
  • Bjorn Brennhovd, Karol Axcrona, Sophie D. Fossa, Karl-Erik Giercksky, Ljiljana Vlatkovic, and Alv A. Dahl, “Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: A controlled study of operative and short-term postoperative events,” Scandinavian Journal of Urology, vol. 47, no. 6, pp. 449–455, 2013. View at Publisher · View at Google Scholar
  • Marina Ivanovic, Xinchun Zhou, Michael P. Gailey, Zhi He, Alan D. Penman, Steven J. Dias, Anait S. Levenson, Swati Dhar, Liangfen Zhang, and Srinivasan Vijayakumar, “Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans,” Scientific Reports, vol. 3, 2013. View at Publisher · View at Google Scholar
  • Michael Rehman, and Luca Tamagnone, “Semaphorins in cancer: Biological mechanisms and therapeutic approaches,” Seminars in Cell & Developmental Biology, vol. 24, no. 3, pp. 179–189, 2013. View at Publisher · View at Google Scholar
  • Jean Hoffman-Censits, and Maofu Fu, “Chemotherapy and Targeted Therapies: Are We Making Progress in Castrate-Resistant Prostate Cancer?,” Seminars in Oncology, vol. 40, no. 3, pp. 361–374, 2013. View at Publisher · View at Google Scholar
  • Carlos E. Rodriguez-Diaz, “Sexual Health Promotion and the Attention to the Social Determinants of Health in the Caribbean,” Sexuality Research and Social Policy, 2013. View at Publisher · View at Google Scholar
  • T. Langsenlehner, C. Döller, P. Winkler, G. Gallé, and K.S. Kapp, “Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins,” Strahlentherapie und Onkologie, vol. 189, no. 4, pp. 321–328, 2013. View at Publisher · View at Google Scholar
  • M. Guckenberger, I. Lawrenz, and M. Flentje, “Moderately hypofractionated radiotherapy for localized prostate cancer,” Strahlentherapie und Onkologie, 2013. View at Publisher · View at Google Scholar
  • Gurdarshan S. Sandhu, Kenneth G. Nepple, Youssef S. Tanagho, and Gerald L. Andriole, “Laparoscopic Prostatectomy for Prostate Cancer,” Surgical Oncology Clinics of North America, vol. 22, no. 1, pp. 125–141, 2013. View at Publisher · View at Google Scholar
  • Natasa Tesic, and Maja Cemazar, “In Vitro Targeted Gene Electrotransfer to Endothelial Cells with Plasmid DNA Containing Human Endothelin-1 Promoter,” The Journal of Membrane Biology, 2013. View at Publisher · View at Google Scholar
  • Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim, and Sven Perner, “ Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer ,” The Journal of Pathology, vol. 231, no. 4, pp. 505–516, 2013. View at Publisher · View at Google Scholar
  • H. Ballentine Carter, Peter C. Albertsen, Michael J. Barry, Ruth Etzioni, Stephen J. Freedland, Kirsten Lynn Greene, Lars Holmberg, Philip Kantoff, Badrinath R. Konety, Mohammad Hassan Murad, David F. Penson, and Anthony L. Zietman, “Early Detection of Prostate Cancer: AUA Guideline,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Debasish Sundi, Oleksandr N. Kryvenko, H. Ballentine Carter, Ashley E. Ross, Jonathan I. Epstein, and Edward M. Schaeffer, “Pathological Examination of Radical Prostatectomy Specimens in Men with Very Low Risk Disease at Biopsy Reveals Distinct Zonal Distribution of Cancer in Black American Men,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Minyi He, Yun Liu, Xinjun Deng, Songtao Qi, Xuegang Sun, Gang Liu, Yongguang Liu, Yawei Liu, and Ming Zhao, “Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Raymond B. Nagle, Amit M. Algotar, Connie C. Cortez, Katherine Smith, Carol Jones, Ubaradka G. Sathyanarayana, Steven Yun, Janice Riley, Dea Nagy, Ryan Dittamore, Bruce Dalkin, Laura Brosh, and Gary Pestano, “ERG Overexpression and PTEN Status Predict Capsular Penetration in Prostate Carcinoma,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Roger A. Vaughan, Randi Garcia-Smith, Kristina A. Trujillo, and Marco Bisoffi, “Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Ahmet Tefekli, and Murat Tunc, “Future Prospects in the Diagnosis and Management of Localized Prostate Cancer,” The Scientific World Journal, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Yi Zhang, Hao Hu, Lu Song, Lin Cai, Renxiong Wei, and Wei Jin, “Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation,” Toxicology Letters, 2013. View at Publisher · View at Google Scholar
  • Bao-Sheng Wang, Zhen Liu, Wei-Xue Xu, and Shao-Long Sun, “CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression,” Tumor Biology, 2013. View at Publisher · View at Google Scholar
  • Yun-Sok Ha, Amirali Salmasi, Michael Karellas, Eric A. Singer, Jeong Hyun Kim, Misop Han, Alan W. Partin, Wun-Jae Kim, Dong Hyeon Lee, and Isaac Yi Kim, “Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance,” Urology, vol. 81, no. 4, pp. 831–836, 2013. View at Publisher · View at Google Scholar
  • Milan Hora, Petr Stransky, Jiri Klecka, Ivan Travnicek, Tomas Uerge, Viktor Eret, Jiri Ferda, Fredrik Petersson, and Ondrej Hes, “Managing urine leakage following laparoscopic radical prostatectomy with active suction of the prevesical space,” Videosurgery And Other Miniinvasive Techniques, vol. 8, no. 1, pp. 49–54, 2013. View at Publisher · View at Google Scholar
  • Mearini Luigi, “High intensity focused ultrasound, liver disease and bridging therapy,” World Journal of Gastroenterology, vol. 19, no. 43, pp. 7494–7499, 2013. View at Publisher · View at Google Scholar
  • Cristina Falavolti, Federico Sergi, Ervin Shehu, and Maurizio Buscarini, “York Mason Procedure to Repair Iatrogenic Rectourinary Fistula: Our Experience,” World Journal of Surgery, 2013. View at Publisher · View at Google Scholar
  • Pierre Colin, Serge Mordon, Pierre Nevoux, Mohammed Feras Marqa, Adil Ouzzane, Philippe Puech, Gregory Bozzini, Bertrand Leroux, Arnauld Villers, and Nacim Betrouni, “Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future,” Advances in Urology, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Andrew Rundle, Kathryn M. Neckerman, Daniel Sheehan, Michelle Jankowski, Oleksandr N. Kryvenko, Deliang Tang, and Benjamin A. Rybicki, “A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer,” Cancer Causes & Control, vol. 24, no. 2, pp. 297–303, 2012. View at Publisher · View at Google Scholar
  • Jacqueline M. Major, M. Norman Oliver, Chyke A. Doubeni, Albert R. Hollenbeck, Barry I. Graubard, and Rashmi Sinha, “Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study,” Cancer Causes & Control, vol. 23, no. 7, pp. 1185–1191, 2012. View at Publisher · View at Google Scholar
  • Afshin Varzavand, Justin M. Drake, Robert U. Svensson, Mary E. Herndon, Bo Zhou, Michael D. Henry, and Christopher S. Stipp, “Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization,” Clinical & Experimental Metastasis, vol. 30, no. 4, pp. 541–552, 2012. View at Publisher · View at Google Scholar
  • Tobias Lange, Sebastian Ullrich, Imke Mueller, Michael F. Nentwich, Katrin Stuebke, Susanne Feldhaus, Christine Knies, Olaf J. C. Hellwinkel, Robert L. Vessella, Claudia Abramjuk, Mario Anders, Jennifer Schroeder-Schwarz, Thorsten Schlomm, Hartwig Huland, Guido Sauter, and Udo Schumacher, “Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of beta(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression,” Clinical Cancer Research, vol. 18, no. 5, pp. 1364–1373, 2012. View at Publisher · View at Google Scholar
  • Henk G. van der Poel, Oscar R. Brouwer, Nynke S. van den Berg, Tessa Buckle, and Fijs W. B. van Leeuwen, “Reply to Karol Polom, Dawid Murawa, Wojciech Polom's Letter to the Editor re: Henk G. van der Poel, Tessa Buckle, Oscar R. Brouwer, Renato A. Valdes Olmos, Fijs WB van Leeuwen. Intraoperative Laparoscopic Fluorescence Guidance to the Sentinel Lymph Node in Prostate Cancer Patients: Clinical Proof of Concept of an Integrated Functional Imaging Approach Using a Multimodal Tracer. Eur Urol 2011;60:826-33,” European Urology, vol. 61, no. 3, pp. E19–E20, 2012. View at Publisher · View at Google Scholar
  • Alexander C Small, and William K Oh, “Bevacizumab treatment of prostate cancer,” Expert Opinion on Biological Therapy, vol. 12, no. 9, pp. 1241–1249, 2012. View at Publisher · View at Google Scholar
  • David Shapiro, and Basir Tareen, “Current and emerging treatments in the management of castration-resistant prostate cancer,” Expert Review of Anticancer Therapy, vol. 12, no. 7, pp. 951–964, 2012. View at Publisher · View at Google Scholar
  • Sma Rizvi, Bj Allen, Cs Lee, F Bruchertseifer, C Apostolidis, A Morgenstern, and Ra Clarke, “ Orthotopic administration of 213 Bi–bevacizumab inhibits progression of PC3 xenografts in the prostate ,” Immunotherapy, vol. 4, no. 5, pp. 549–554, 2012. View at Publisher · View at Google Scholar
  • Sina Grebhardt, Christian Veltkamp, Philipp Ströbel, and Doris Mayer, “Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer,” International Journal of Cancer, vol. 131, no. 12, pp. 2785–2794, 2012. View at Publisher · View at Google Scholar
  • Jennifer J. Salinas, Manasi Shah, Bassent Abdelbary, Jennifer L. Gay, and Ken Sexton, “Application of a Novel Method for Assessing Cumulative Risk Burden by County,” International Journal of Environmental Research and Public Health, vol. 9, no. 12, pp. 1820–1835, 2012. View at Publisher · View at Google Scholar
  • Hideaki Miyake, and Masato Fujisawa, “Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches,” International Journal of Urology, vol. 20, no. 3, pp. 301–311, 2012. View at Publisher · View at Google Scholar
  • Shin Ogita, Sheela Tejwani, Lance Heilbrun, Joseph Fontana, Elisabeth Heath, Stacy Freeman, Daryn Smith, Karen Baranowski, and Ulka Vaishampayan, “Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer,” ISRN Oncology, vol. 2012, pp. 1–7, 2012. View at Publisher · View at Google Scholar
  • G. S. Sandhu, and G. L. Andriole, “Overdiagnosis of Prostate Cancer,” JNCI Monographs, vol. 2012, no. 45, pp. 146–151, 2012. View at Publisher · View at Google Scholar
  • Patricia Ng, Elinor R. Schoenfeld, Anselm Hennis, Suh-Yuh Wu, M. Cristina Leske, and Barbara Nemesure, “Factors Influencing Prostate Cancer Healthcare Practices in Barbados, West Indies,” Journal of Immigrant and Minority Health, vol. 15, no. 3, pp. 653–660, 2012. View at Publisher · View at Google Scholar
  • Barbara Nemesure, Suh-Yuh Wu, Anselm Hennis, and M. Cristina Leske, “Family History of Prostate Cancer in a Black Population,” Journal of Immigrant and Minority Health, vol. 15, no. 6, pp. 1107–1112, 2012. View at Publisher · View at Google Scholar
  • Jiaming Liu, Jin Huang, Yazhou He, Jinnan Liu, Banghua Liao, and Ga Liao, “Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer,” Molecular Carcinogenesis, 2012. View at Publisher · View at Google Scholar
  • Olivier Rouviere, Albert Gelet, Sebastien Crouzet, and Jean-Yves Chapelon, “Prostate focused ultrasound focal therapy-imaging for the future,” Nature Reviews Clinical Oncology, vol. 9, no. 12, pp. 721–727, 2012. View at Publisher · View at Google Scholar
  • Xiaobin Wang, Zhikun Ma, Zheng Xiao, Hui Liu, Zhongling Dou, Xiaoshan Feng, and Haijun Shi, “Chk1 knockdown confers radiosensitization in prostate cancer stem cells,” Oncology Reports, vol. 28, no. 6, pp. 2247–2254, 2012. View at Publisher · View at Google Scholar
  • Alina Wozniak, Rafal Masiak, Michal Szpinda, Celestyna Mila-Kierzenkowska, Bartosz Wozniak, Roman Makarewicz, and Anna Szpinda, “Oxidative Stress Markers in Prostate Cancer Patients after HDR Brachytherapy Combined with External Beam Radiation,” Oxidative Medicine and Cellular Longevity, vol. 2012, pp. 1–5, 2012. View at Publisher · View at Google Scholar
  • Ravi Shukla, Nripen Chanda, Ajit Zambre, Anandhi Upendran, Kavita Katti, Rajesh R. Kulkarni, Satish Kumar Nune, Stan W. Casteel, Charles Jeffrey Smith, Jatin Vimal, Evan Boote, J. David Robertson, Para Kan, Hendrik Engelbrecht, Lisa D. Watkinson, Terry L. Carmack, John R. Lever, Cathy S. Cutler, Charles Caldwell, Raghuraman Kannan, and Kattesh V. Katti, “Laminin receptor specific therapeutic gold nanoparticles ((AuNP)-Au-198-EGCg) show efficacy in treating prostate cancer,” Proceedings Of The National Academy Of Sciences Of The United States Of Ame, vol. 109, no. 31, pp. 12426–12431, 2012. View at Publisher · View at Google Scholar
  • James R. Marthick, and Joanne L. Dickinson, “Emerging Putative Biomarkers: The Role of Alpha 2 and 6 Integrins in Susceptibility, Treatment, and Prognosis,” Prostate Cancer, vol. 2012, pp. 1–9, 2012. View at Publisher · View at Google Scholar
  • Kristina A. Trujillo, Anna C. Jones, Jeffrey K. Griffith, and Marco Bisoffi, “Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies,” Prostate Cancer, vol. 2012, pp. 1–12, 2012. View at Publisher · View at Google Scholar
  • Subhashini Yaturu, Sonya Zdunek, and Barbara Youngberg, “Vitamin D Levels in Subjects with Prostate Cancer Compared to Age-Matched Controls,” Prostate Cancer, vol. 2012, pp. 1–4, 2012. View at Publisher · View at Google Scholar
  • M R Abern, M R Bassett, M Tsivian, L L Bañez, T J Polascik, M N Ferrandino, C N Robertson, S J Freedland, and J W Moul, “Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center,” Prostate Cancer and Prostatic Diseases, vol. 16, no. 1, pp. 85–90, 2012. View at Publisher · View at Google Scholar
  • Sangeet Ghai, and Ants Toi, “Role of Transrectal Ultrasonography in Prostate Cancer,” Radiologic Clinics of North America, vol. 50, no. 6, pp. 1061–1073, 2012. View at Publisher · View at Google Scholar
  • Marie-Louise Vrang, Martin Andreas Røder, Ben Vainer, Ib Jarle Christensen, Lisa Gruschy, Klaus Brasso, and Peter Iversen, “First danish single-institution experience with radical prostatectomy: impact of surgical margins on biochemical outcome,” Scandinavian Journal of Urology and Nephrology, vol. 46, no. 3, pp. 172–179, 2012. View at Publisher · View at Google Scholar
  • Carina Mari Aparici, and Youngho Seo, “Functional Imaging for Prostate Cancer: Therapeutic Implications,” Seminars in Nuclear Medicine, vol. 42, no. 5, pp. 328–342, 2012. View at Publisher · View at Google Scholar
  • Lara Tamburrino, Francesca Salvianti, Sara Marchiani, Pamela Pinzani, Gabriella Nesi, Sergio Serni, Gianni Forti, and Elisabetta Baldi, “Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens,” Steroids, vol. 77, no. 10, pp. 996–1001, 2012. View at Publisher · View at Google Scholar
  • A. M. Borowiec, M. McCall, and G. M. Lees, “The trans-sphincteric posterior sagittal repair of recto-urinary and recto-vaginal fistulae using Surgisis™ mesh and fibrin sealant,” Techniques in Coloproctology, vol. 18, no. 2, pp. 201–203, 2012. View at Publisher · View at Google Scholar
  • Keely M. McNamara, David J. Handelsman, and Ulla Simanainen, “The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 131, no. 3-5, pp. 107–121, 2012. View at Publisher · View at Google Scholar
  • Ari Adamy, “Editorial Comment,” The Journal of Urology, vol. 187, no. 5, pp. 1599–1600, 2012. View at Publisher · View at Google Scholar
  • Misop Han, Doyoung Chang, Chunwoo Kim, Brian J. Lee, Yihe Zuo, Hyung-Joo Kim, Doru Petrisor, Bruce Trock, Alan W. Partin, Ronald Rodriguez, H. Ballentine Carter, Mohamad Allaf, Jongwon Kim, and Dan Stoianovici, “Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy,” The Journal of Urology, vol. 188, no. 6, pp. 2404–2409, 2012. View at Publisher · View at Google Scholar
  • Jen-Jane Liu, Michelle Ferrari, Rosie Nolley, James D. Brooks, and Joseph C. Presti, “Performance Characteristics of Prostate-specific Antigen in Patients Undergoing Radical Prostatectomy,” Urology, vol. 79, no. 6, pp. 1336–1339, 2012. View at Publisher · View at Google Scholar
  • Roger Valdivieso O'Donova, Pierre-Alain Hueber, and Kevin C. Zorn, “Editorial Comment,” Urology, vol. 80, no. 3, pp. 582–583, 2012. View at Publisher · View at Google Scholar
  • W.D. Aiken, “Historical determinants of contemporary attributes of African descendants in the Americas: The androgen receptor holds the key,” Medical Hypotheses, vol. 77, no. 6, pp. 1121–1124, 2011. View at Publisher · View at Google Scholar
  • Andrea Benedetto Galosi, Giovanni Muzzonigro, Vito Lacetera, and Roberta Mazzucchelli, “Specimen Orientation by Marking the Peripheral End: (Potential) Clinical Advantages in Prostate Biopsy,” Prostate Cancer, vol. 2011, pp. 1–7, 2011. View at Publisher · View at Google Scholar